Search company, investor...
InSite Vision company logo

InSite Vision

Founded Year



Acq - P2P | Acquired

About InSite Vision

InSite Vision develops topical anti-infective products, including AzaSite(R) (azithromycin ophthalmic solution) 1%.

Headquarters Location

965 Atlantic Avenue

Alameda, California, 94501,

United States


Missing: InSite Vision's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: InSite Vision's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

InSite Vision Patents

InSite Vision has filed 11 patents.

patents chart

Application Date

Grant Date


Related Topics




Adenosine receptor antagonists, Purines, Xanthines, Nucleotides, Immunosuppressants


Application Date


Grant Date



Related Topics

Adenosine receptor antagonists, Purines, Xanthines, Nucleotides, Immunosuppressants



Latest InSite Vision News

Stye Drug Market Potential Growth, Share, Demand And Analysis Of Key Players- Research Forecasts To 2027 || Novartis AG, Johnson & Johnson Services, Inc., Bausch Health, Sun Pharmaceutical Industries Ltd, ALLERGAN, Merck & Co., Inc, Pfizer

Apr 29, 2021

Search jobs 29-Apr-2021 Stye Drug Market Potential Growth, Share, Demand And Analysis Of Key Players- Research Forecasts To 2027 || Novartis AG, Johnson & Johnson Services, Inc., Bausch Health, Sun Pharmaceutical Industries Ltd, ALLERGAN, Merck & Co., Inc, Pfizer Stye Drug Market research report conducts study on production capacity, consumption, import, and export for all major regions across the globe. The report is a professional in-depth study on the current state of the market. Analysis and discussion of important industry trends, market size, and market share estimates are revealed in the report. The market report also contains the drivers and restraints for Stye Drug Market that are derived from SWOT analysis, and also shows all the recent developments, product launches, joint ventures, mergers, and acquisitions by the several key players and brands that are driving the market by systemic company profiles. This report covers a very important aspect which is competitive intelligence and with this businesses can gain a competitive advantage to thrive in the market. This market analysis report also encompasses far-reaching research on the current conditions of the Industry, the potential of the market in the present, and the future prospects. What is more, this market research report also contains details about market analysis, market definition, market segmentation, key development areas, competitive analysis, and research methodology. Global stye drug market is rising gradually with a substantial CAGR in the forecast period of 2019-2026. Growing population of stye population worldwide and emergence of drugs used in the treatment of risk associated with stye disease are the key factors to drive the market growth. Key Competitors: Few of the major competitors currently working in the global stye drug market are Novartis AG, Johnson & Johnson Services, Inc., Bausch Health, Sun Pharmaceutical Industries Ltd, ALLERGAN, Merck & Co., Inc, Pfizer Inc, XOMA, EyePoint Pharmaceuticals, Enzo Biochem Inc., AbbVie Inc, TopiVert Ltd, Santen Pharmaceutical Co., Ltd., Regeneron Pharmaceuticals Inc, HanAll Biopharma, DAIICHI SANKYO COMPANY, LIMITED, Alphamab Co. Ltd, Coherus BioSciences, Ligand Pharmaceuticals Incorporated, Clearside Biomedical, Inc. and many others. Some of the Major Highlights of TOC covers: Chapter 1: Methodology & Scope Some Notable Report Offerings: – We will provide you an analysis of the extent to which this market research report acquires commercial characteristics along with examples or instances of information that helps you to understand it better. – We will also help to identify customary/ standard terms and conditions, as offers, worthiness, warranty, and others. – Also, this report will help you to identify any trends to forecast growth rates. – The analyzed report will forecast the general tendency for supply and demand. Key Offerings: -Market Dynamics – Leading trends, growth drivers, restraints, and investment opportunities -Market Segmentation – A detailed analysis by product, by types, end-user, applications, segments, and geography Get Detailed Table of Content: Market Drivers Exposure to certain toxin or change in environment may increase the stye infections Prevalence of indoor as well as outdoor allergens Increase in prevalence rate of stye disease worldwide Market Restraints Patent expiry from many companies and introduction of generic drugs is expected to restrain the growth if the market. Inadequate knowledge about stye disease in some developing countries Reason to Buy: Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments. Highlights key business priorities in order to assist companies to realign their business strategies. The key findings and recommendations highlight crucial progressive industry trends thereby allowing players to develop effective long-term strategies. Develop/modify business expansion plans by using substantial growth offering developed and emerging markets. Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it. Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to products, segmentation, and industry verticals. Note: If You Have Any Special Requirements, Please Let Us Know And We Will Offer You The Report As You Want. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate. Key Developments in the Market: In August 2018, Senju USA, Inc. conducting phase III (SUNRISE) clinical trial for their lead candidate SUN 131 TDS to evaluate the safety and efficacy in patients with chalazion. If approved it will represent a new and significant treatment options for chalazion. In September 2015, Sun Pharmaceutical Industries Ltd acquired InSite Vision Inc for up to USD 48.00mm. The acquisitions of InSite Vision Inc, strengthens the branded ophthalmic portfolio of Sun Pharmaceutical Industries Ltd in the United States. Top Trending Reports: Why Go For Data Bridge Market Research? Data Bridge Market Research is a versatile market research and consulting firm with over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies  ly and have a network of more than 5000+ clientele around the globe. Our coverage of industries include Medical Devices, Pharmaceuticals, Biotechnology, Semiconductors, Machinery, Information and Communication Technology, Automobiles and Automotive, Chemical and Material, Packaging, Food and Beverages, Cosmetics, Specialty Chemicals, Fast Moving Consumer Goods, Robotics, among many others. We provide a variety of services such as market verified industry reports, technology trend analysis, Formative market research, strategic consulting, vendor analysis, production and demand analysis, consumer impact studies among many others. Contact:

InSite Vision Frequently Asked Questions (FAQ)

  • When was InSite Vision founded?

    InSite Vision was founded in 1986.

  • Where is InSite Vision's headquarters?

    InSite Vision's headquarters is located at 965 Atlantic Avenue, Alameda.

  • What is InSite Vision's latest funding round?

    InSite Vision's latest funding round is Acq - P2P.

  • Who are the investors of InSite Vision?

    Investors of InSite Vision include QLT, PTV Sciences, BAM Elevate, Visium Asset Management, Wellington Management and 32 more.

  • Who are InSite Vision's competitors?

    Competitors of InSite Vision include Stealth Therapeutics, Byram Healthcare, Degania Medical, Heartsine, TIDI Products and 12 more.

Compare InSite Vision to Competitors

Smart Medical Group

Smart Medical Group is the headquarters of a group of medical supply companies. It has its own R&D and production activities and is represented worldwide by a network of distributors. The Smart Medical Group aims to manage direct sales forces in Spain and the United Kingdom. Read more Strives for commercial excellence by offering a product range that satisfies the client's needs.

Proxy Biomedical Logo
Proxy Biomedical

Proxy Biomedical, headquartered in Galway, Ireland, is engaged in the development and manufacturing of surgical products that apply synthetic biomaterials technology for tissue regeneration.


The biomedical startup specializes in advanced biosynthetic dressings for treating wounds and burns. E. Aubrey Woodroof, a wound care specialist, founded Aubrey in 2007 to commercialize a dressing he had developed that has microscopic web-like interconnections and continuous pores throughout the dressing.

Care Dynamix

Care Dynamix is a provider of cost-efficient, high quality onsite vaccination clinics at U.S. companies, schools and retail locations of every size.

Simplex Diabetic Supply

Simplex was founded in April 2007 to provide home delivery of medical supplies to help patients with diabetes.

Yulex Logo

Yulex Corporation is a medical device company. It had developed the Yulex Latex Powder-free Exam Gloves.Yulex Corporation applies intelligent crop science and proprietary clean technology to create medical and biobased industrial products from guayule. Yulex natural rubber, produced from guayule, is replacing synthetic, petroleum-based materials as well as Hevea latex in a range of medical products.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.